India to Turkey: Vaccine Export Trade Route

The India to Turkey Vaccine corridor is one of India's established pharmaceutical export routes, with 308 shipments documented worth a combined $40.6M USD. The route is dominated by SERUM INSTITUTE OF INDIA PRIVATE LIMITED, which alone accounts for roughly 46% of all export value, reflecting the consolidated nature of India's vaccine manufacturing sector.

Across 26 active suppliers, the average shipment value stands at $131.9K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 81% of all shipments, consistent with vaccine's non-urgent bulk-order profile.

Shipment activity peaks during October–December, with an average transit time of 23 days port-to-port. The route has recorded an annual growth rate of 31.1%, placing it at rank #14 among India's top vaccine export destinations globally.

On the import side, key buyers of Indian vaccine in Turkey include CENTURION ILAC SANAYI VE TICARET AN, KEYMEN ILAC SANAYI VE TICARET A.S, CENTURION ILAC SANAYI VE TICARET and 62 others. CENTURION ILAC SANAYI VE TICARET AN is the single largest importer with 41 shipments valued at $11.6M USD.

India's vaccine exports to Turkey are driven primarily by a handful of large-scale manufacturers. SERUM INSTITUTE OF INDIA PRIVATE LIMITED with 98 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 26 active exporters signals a competitive but concentrated market — buyers in Turkey benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — SERUM INSTITUTE OF INDIA PRIVATE LIMITED, INDIAN IMMUNOLOGICALS LIMITED, SERUM INSTITUTE OF INDIA PRIVATE LIMITED — together account for 95% of total trade value on this route. The average shipment value of $131.9K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as mixed vaccine for mmr-viral vaccine- and abhayrab 0.5mlhuman rabies vaccine with, suggesting that buyers in Turkey tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, CENTURION ILAC SANAYI VE TICARET AN is the largest importer with 41 shipments worth $11.6M USD — representing 29% of all vaccine imports from India on this route. A total of 65 buyers are active on this corridor.